Fishing for causes and cures of motor neuron disorders

DMM Disease Models and Mechanisms

Volumn 7, Issue 7, 2014, Pages 799-809

  Patten, Shunmoogum A ^a   Armstrong, Gary A B ^a   Lissouba, Alexandra ^a   Kabashi, Edor ^b   Parker, J Alex ^a   Drapeau, Pierre ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

ALS; Drug discovery; HSP; Motor neuron disorders; SMA; Zebrafish

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; HEREDITARY MOTOR SENSORY NEUROPATHY; MOTOR NEURON DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SPINAL MUSCULAR ATROPHY; ZEBRA FISH; ANIMAL; DISEASE MODEL; DRUG SCREENING; HUMAN; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; HUMANS; MOTOR NEURON DISEASE; SIGNAL TRANSDUCTION; ZEBRAFISH;

EID: 84903948781     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.015719     Document Type: Review

References (128)

1. Achsel, T., Barabino, S., Cozzolino, M. and Carrì, M. T. (2013). The intriguing case of motor neuron disease: ALS and SMA come closer. Biochem. Soc. Trans. 41, 1593-1597.
2. Akten, B., Kye, M. J., Hao, T., Wertz, M. H., Singh, S., Nie, D., Huang, J., Merianda, T. T., Twiss, J. L., Beattie, C. E. et al. (2011). Interaction of survival of motor neuron (SMN) and HuD proteins with mRNA cpg15 rescues motor neuron axonal deficits. Proc. Natl. Acad. Sci. USA 108, 10337-10342.
3. Andersen, P. M. and Al-Chalabi, A. (2011). Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat. Rev. Neurol. 7, 603-615.
4. Arai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y. et al. (2006). TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 351, 602-611. (Pubitemid 44708852)
5. Armstrong, G. A. B. and Drapeau, P. (2013a). Calcium channel agonists protect against neuromuscular dysfunction in a genetic model of TDP-43 mutation in ALS. J. Neurosci. 33, 1741-1752.
6. Armstrong, G. A. B. and Drapeau, P. (2013b). Loss and gain of FUS function impair neuromuscular synaptic transmission in a genetic model of ALS. Hum. Mol. Genet. 22, 4282-4292.
7. Asnani, A. and Peterson, R. T. (2014). The zebrafish as a tool to identify novel therapies for human cardiovascular disease. Dis. Model. Mech. 7, 763-767
8. Baraban, S. C., Dinday, M. T. and Hortopan, G. A. (2013). Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet syndrome treatment. Nat. Commun. 4, 2410.
9. Blackstone, C. (2012). Cellular pathways of hereditary spastic paraplegia. Annu. Rev. Neurosci. 35, 25-47.
10. Boillée, S., Vande Velde, C. and Cleveland, D. W. (2006). ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52, 39-59. (Pubitemid 44466358)
11. Boon, K.-L., Xiao, S., McWhorter, M. L., Donn, T., Wolf-Saxon, E., Bohnsack, M. T., Moens, C. B. and Beattie, C. E. (2009). Zebrafish survival motor neuron mutants exhibit presynaptic neuromuscular junction defects. Hum. Mol. Genet. 18, 3615-3625.
12. Bories, C., Amendola, J., Lamotte d'Incamps, B. and Durand, J. (2007). Early electrophysiological abnormalities in lumbar motoneurons in a transgenic mouse model of amyotrophic lateral sclerosis. Eur. J. Neurosci. 25, 451-459.
13. Bosco, D. A., Lemay, N., Ko, H. K., Zhou, H., Burke, C., Kwiatkowski, T. J., Jr, Sapp, P., McKenna-Yasek, D., Brown, R. H., Jr and Hayward, L. J. (2010). Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. Hum. Mol. Genet. 19, 4160-4175.
14. Butler, R., Wood, J. D., Landers, J. A. and Cunliffe, V. T. (2010). Genetic and chemical modulation of spastin-dependent axon outgrowth in zebrafish embryos indicates a role for impaired microtubule dynamics in hereditary spastic paraplegia. Dis. Model. Mech. 3, 743-751.
15. Carrel, T. L., McWhorter, M. L., Workman, E., Zhang, H., Wolstencroft, E. C., Lorson, C., Bassell, G. J., Burghes, A. H. and Beattie, C. E. (2006). Survival motor neuron function in motor axons is independent of functions required for small nuclear ribonucleoprotein biogenesis. J. Neurosci. 26, 11014-11022. (Pubitemid 44772191)
16. Chan, J. and Mably, J. D. (2011). Dissection of cardiovascular development and disease pathways in zebrafish. Prog. Mol. Biol. Transl. Sci. 100, 111-153.
17. Chen, S., Sayana, P., Zhang, X. and Le, W. (2013). Genetics of amyotrophic lateral sclerosis: an update. Mol. Neurodegener. 8, 28.
18. Chico, T. J., Ingham, P. W. and Crossman, D. C. (2008). Modeling cardiovascular disease in the zebrafish. Trends Cardiovasc. Med. 18, 150-155. (Pubitemid 351794544)
19. Chitramuthu, B. P., Baranowski, D. C., Kay, D. G., Bateman, A. and Bennett, H. P. (2010). Progranulin modulates zebrafish motoneuron development in vivo and rescues truncation defects associated with knockdown of Survival motor neuron 1. Mol. Neurodegener. 5, 41.
20. Ciura, S., Lattante, S., Le Ber, I., Latouche, M., Tostivint, H., Brice, A. and Kabashi, E. (2013). Loss of function of C9orf72 causes motor deficits in a zebrafish model of Amyotrophic Lateral Sclerosis. Annals of Neurology
21. Cozzolino, M. and Carrì, M. T. (2012). Mitochondrial dysfunction in ALS. Prog. Neurobiol. 97, 54-66.
22. Da Costa, M. M., Allen, C. E., Higginbottom, A., Ramesh, T., Shaw, P. J. and McDermott, C. J. (2014). A new zebrafish model produced by TILLING of SOD1-related amyotrophic lateral sclerosis replicates key features of the disease and represents a tool for in vivo therapeutic screening. Dis. Model. Mech. 7, 73-81.
23. Da Cruz, S. and Cleveland, D. W. (2011). Understanding the role of TDP-43 and FUS/TLS in ALS and beyond. Curr. Opin. Neurobiol. 21, 904-919.
24. Dadon-Nachum, M., Melamed, E. and Offen, D. (2011). The "dying-back" phenomenon of motor neurons in ALS. J. Mol. Neurosci. 43, 470-477.
25. DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J. et al. (2011). Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72, 245-256.
26. Deng, H. X., Zhai, H., Fu, R., Shi, Y., Gorrie, G. H., Yang, Y., Liu, E., Dal Canto, M. C., Mugnaini, E. and Siddique, T. (2007). Distal axonopathy in an alsin-deficient mouse model. Hum. Mol. Genet. 16, 2911-2920. (Pubitemid 350048388)
27. Dion, P. A., Daoud, H. and Rouleau, G. A. (2009). Genetics of motor neuron disorders: new insights into pathogenic mechanisms. Nat. Rev. Genet. 10, 769-782.
28. Dormann, D., Rodde, R., Edbauer, D., Bentmann, E., Fischer, I., Hruscha, A., Than, M. E., Mackenzie, I. R., Capell, A., Schmid, B. et al. (2010). ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J. 29, 2841-2857.
29. Fassier, C., Hutt, J. A., Scholpp, S., Lumsden, A., Giros, B., Nothias, F., Schneider-Maunoury, S., Houart, C. and Hazan, J. (2010). Zebrafish atlastin controls motility and spinal motor axon architecture via inhibition of the BMP pathway. Nat. Neurosci. 13, 1380-1387.
30. Fink, J. K. (2013). Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms. Acta Neuropathol. 126, 307-328.
31. Finsterer, J., Löscher, W., Quasthoff, S., Wanschitz, J., Auer-Grumbach, M. and Stevanin, G. (2012). Hereditary spastic paraplegias with autosomal dominant, recessive, X-linked, or maternal trait of inheritance. J. Neurol. Sci. 318, 1-18.
32. Flinn, L., Bretaud, S., Lo, C., Ingham, P. W. and Bandmann, O. (2008). Zebrafish as a new animal model for movement disorders. J. Neurochem. 106, 1991-1997.
33. Gassman, A., Hao, T., Bhoite, L., Bradford, C. L., Chien, C. B., Beattie, C. E. and Manfredi, J. P. (2013). Small molecule suppressors of Drosophila kinesin deficiency rescue motor axon development in a zebrafish model of spinal muscular atrophy. PLoS ONE 8, e74325.
34. Gendron, T. F., Belzil, V. V., Zhang, Y. J. and Petrucelli, L. (2014). Mechanisms of toxicity in C9FTLD/ALS. Acta Neuropathol. 127, 359-376.
35. Gerlai, R. (2010). High-throughput behavioral screens: the first step towards finding genes involved in vertebrate brain function using zebrafish. Molecules 15, 2609-2622.
36. Giacomotto, J. and Ségalat, L. (2010). High-throughput screening and small animal models, where are we? Br. J. Pharmacol. 160, 204-216.
37. Godena, V. K., Romano, G., Romano, M., Appocher, C., Klima, R., Buratti, E., Baralle, F. E. and Feiguin, F. (2011). TDP-43 regulates Drosophila neuromuscular junctions growth by modulating Futsch/MAP1B levels and synaptic microtubules organization. PLoS ONE 6, e17808.
38. Greenberg, F., Fenolio, K. R., Hejtmancik, J. F., Armstrong, D., Willis, J. K., Shapira, E., Huntington, H. W. and Haun, R. L. (1988). X-linked infantile spinal muscular atrophy. Am. J. Dis. Child. 142, 217-219. (Pubitemid 18081267)
39. Gros-Louis, F., Kriz, J., Kabashi, E., McDearmid, J., Millecamps, S., Urushitani, M., Lin, L., Dion, P., Zhu, Q., Drapeau, P. et al. (2008). Als2 mRNA splicing variants detected in KO mice rescue severe motor dysfunction phenotype in Als2 knock-down zebrafish. Hum. Mol. Genet. 17, 2691-2702.
40. Halpern, M. E., Rhee, J., Goll, M. G., Akitake, C. M., Parsons, M. and Leach, S. D. (2008). Gal4/UAS transgenic tools and their application to zebrafish. Zebrafish 5, 97-110. (Pubitemid 351860474)
41. Hamilton, G. and Gillingwater, T. H. (2013). Spinal muscular atrophy: going beyond the motor neuron. Trends Mol. Med. 19, 40-50.
42. Hao, T., Burghes, A. H. and Beattie, C. E. (2011). Generation and characterization of a genetic zebrafish model of SMA carrying the human SMN2 gene. Mol. Neurodegener. 6, 24.
43. Hao, T., Wolman, M., Granato, M. and Beattie, C. E. (2012). Survival motor neuron affects plastin 3 protein levels leading to motor defects. J. Neurosci. 32, 5074-5084.
44. Hao, L. T., Duy, P. Q., Jontes, J. D., Wolman, M., Granato, M. and Beattie, C. E. (2013). Temporal requirement for SMN in motoneuron development. Hum. Mol. Genet. 22, 2612-2625.
45. Harding, A. E. (1983). Classification of the hereditary ataxias and paraplegias. Lancet 321, 1151-1155. (Pubitemid 13084682)
46. Hewamadduma, C. A. A., Grierson, A. J., Ma, T. P., Pan, L., Moens, C. B., Ingham, P. W., Ramesh, T. and Shaw, P. J. (2013). Tardbpl splicing rescues motor neuron and axonal development in a mutant tardbp zebrafish. Hum. Mol. Genet. 22, 2376-2386.
47. Howe, K., Clark, M. D., Torroja, C. F., Torrance, J., Berthelot, C., Muffato, M., Collins, J. E., Humphray, S., McLaren, K., Matthews, L. et al. (2013). The zebrafish reference genome sequence and its relationship to the human genome. Nature 496, 498-503.
48. Ilieva, H., Polymenidou, M. and Cleveland, D. W. (2009). Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J. Cell Biol. 187, 761-772.
49. Jao, L. E., Wente, S. R. and Chen, W. (2013). Efficient multiplex biallelic zebrafish genome editing using a CRISPR nuclease system. Proc. Natl. Acad. Sci. USA 110, 13904-13909.
50. Jiang, W., Ji, X., Xu, Y., Qu, X., Sun, W., Yang, Z., Tao, J. and Chen, Y. (2013). Molecular prenatal diagnosis of autosomal recessive spinal muscular atrophies using quantification polymerase chain reaction. Genet. Test Mol. Biomarkers 17, 438-442.
51. Kabashi, E., Valdmanis, P. N., Dion, P., Spiegelman, D., McConkey, B. J., Vande Velde, C., Bouchard, J. P., Lacomblez, L., Pochigaeva, K., Salachas, F. et al. (2008). TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 40, 572-574. (Pubitemid 351601218)
52. Kabashi, E., Champagne, N., Brustein, E. and Drapeau, P. (2010a). In the swim of things: recent insights to neurogenetic disorders from zebrafish. Trends Genet. 26, 373-381.
53. Kabashi, E., Lin, L., Tradewell, M. L., Dion, P. A., Bercier, V., Bourgouin, P., Rochefort, D., Bel Hadj, S., Durham, H. D., Vande Velde, C. et al. (2010b). Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo. Hum. Mol. Genet. 19, 671-683.
54. Kabashi, E., Bercier, V., Lissouba, A., Liao, M., Brustein, E., Rouleau, G. A. and Drapeau, P. (2011a). FUS and TARDBP but not SOD1 interact in genetic models of amyotrophic lateral sclerosis. PLoS Genet. 7, e1002214.
55. Kabashi, E., Brustein, E., Champagne, N. and Drapeau, P. (2011b). Zebrafish models for the functional genomics of neurogenetic disorders. Biochim. Biophys. Acta 1812, 335-345.
56. Kawahara, G., Karpf, J. A., Myers, J. A., Alexander, M. S., Guyon, J. R. and Kunkel, L. M. (2011). Drug screening in a zebrafish model of Duchenne muscular dystrophy. Proc. Natl. Acad. Sci. USA 108, 5331-5336.
57. Khaniani, M. S., Derakhshan, S. M. and Abasalizadeh, S. (2013). Prenatal diagnosis of spinal muscular atrophy: clinical experience and molecular genetics of SMN gene analysis in 36 cases. J. Prenat. Med. 7, 32-34.
58. Kiernan, M. C., Vucic, S., Cheah, B. C., Turner, M. R., Eisen, A., Hardiman, O., Burrell, J. R. and Zoing, M. C. (2011). Amyotrophic lateral sclerosis. Lancet 377, 942-955.
59. Kwiatkowski, T. J., Jr, Bosco, D. A., Leclerc, A. L., Tamrazian, E., Vanderburg, C. R., Russ, C., Davis, A., Gilchrist, J., Kasarskis, E. J., Munsat, T. et al. (2009). Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323, 1205-1208.
60. Lagier-Tourenne, C., Polymenidou, M., Hutt, K. R., Vu, A. Q., Baughn, M., Huelga, S. C., Clutario, K. M., Ling, S. C., Liang, T. Y., Mazur, C. et al. (2012). Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat. Neurosci. 15, 1488-1497.
61. Landouré, G., Zhu, P. P., Lourenço, C. M., Johnson, J. O., Toro, C., Bricceno, K. V., Rinaldi, C., Meilleur, K. G., Sangaré, M., Diallo, O. et al.; NIH Intramural Sequencing Center (2013). Hereditary spastic paraplegia type 43 (SPG43) is caused by mutation in C19orf12. Hum. Mutat. 34, 1357-1360.
62. Lattante, S., Rouleau, G. A. and Kabashi, E. (2013). TARDBP and FUS mutations associated with amyotrophic lateral sclerosis: summary and update. Hum. Mutat. 34, 812-826.
63. Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Benichou, B., Cruaud, C., Millasseau, P., Zeviani, M. et al. (1995). Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80, 155-165.
64. Lemmens, R., Van Hoecke, A., Hersmus, N., Geelen, V., D'Hollander, I., Thijs, V., Van Den Bosch, L., Carmeliet, P. and Robberecht, W. (2007). Overexpression of mutant superoxide dismutase 1 causes a motor axonopathy in the zebrafish. Hum. Mol. Genet. 16, 2359-2365. (Pubitemid 47423902)
65. Lieschke, G. J. and Currie, P. D. (2007). Animal models of human disease: zebrafish swim into view. Nat. Rev. Genet. 8, 353-367. (Pubitemid 46625809)
66. Lin, P., Li, J., Liu, Q., Mao, F., Li, J., Qiu, R., Hu, H., Song, Y., Yang, Y., Gao, G. et al. (2008). A missense mutation in SLC33A1, which encodes the acetyl-CoA transporter, causes autosomal-dominant spastic paraplegia (SPG42). Am. J. Hum. Genet. 83, 752-759.
67. Lin, H. J., Lee, S. H., Wu, J. L., Duann, Y. F. and Chen, J. Y. (2013). Development of Cre-loxP technology in zebrafish to study the regulation of fish reproduction. Fish Physiol. Biochem. 39, 1525-1539.
68. Ling, S. C., Polymenidou, M. and Cleveland, D. W. (2013). Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79, 416-438.
69. Liu, S. and Leach, S. D. (2011a). Screening pancreatic oncogenes in zebrafish using the Gal4/UAS system. Methods Cell Biol. 105, 367-381.
70. Liu, S. and Leach, S. D. (2011b). Zebrafish models for cancer. Annu. Rev. Pathol. 6, 71-93.
71. Lotti, F., Imlach, W. L., Saieva, L., Beck, E. S., Hao, T., Li, D. K., Jiao, W., Mentis, G. Z., Beattie, C. E., McCabe, B. D. et al. (2012). An SMN-dependent U12 splicing event essential for motor circuit function. Cell 151, 440-454.
72. Lyon, A. N., Pineda, R. H., Hao, T., Kudryashova, E., Kudryashov, D. S. and Beattie, C. E. (2014). Calcium binding is essential for plastin 3 function in Smndeficient motoneurons. Hum. Mol. Genet. 23, 1990-2004.
73. Martin, E., Yanicostas, C., Rastetter, A., Naini, S. M., Maouedj, A., Kabashi, E., Rivaud-Péchoux, S., Brice, A., Stevanin, G. and Soussi-Yanicostas, N. (2012). Spatacsin and spastizin act in the same pathway required for proper spinal motor neuron axon outgrowth in zebrafish. Neurobiol. Dis. 48, 299-308.
74. Martin, E., Schüle, R., Smets, K., Rastetter, A., Boukhris, A., Loureiro, J. L., Gonzalez, M. A., Mundwiller, E., Deconinck, T., Wessner, M. et al. (2013). Loss of function of glucocerebrosidase GBA2 is responsible for motor neuron defects in hereditary spastic paraplegia. Am. J. Hum. Genet. 92, 238-244.
75. Matus, S., Valenzuela, V., Medinas, D. B. and Hetz, C. (2013). ER dysfunction and protein folding stress in ALS. Int. J. Cell Biol. 2013, 674751.
76. McGown, A., McDearmid, J. R., Panagiotaki, N., Tong, H., Al Mashhadi, S., Redhead, N., Lyon, A. N., Beattie, C. E., Shaw, P. J. and Ramesh, T. M. (2012). Early interneuron dysfunction in ALS: Insights from a mutant sod1 zebrafish model. Ann. Neurol. 73, 246-258.
77. McGown, A., McDearmid, J. R., Panagiotaki, N., Tong, H., Al Mashhadi, S., Redhead, N., Lyon, A. N., Beattie, C. E., Shaw, P. J. and Ramesh, T. M. (2013). Early interneuron dysfunction in ALS: insights from a mutant sod1 zebrafish model. Ann. Neurol. 73, 246-258.
78. McWhorter, M. L., Monani, U. R., Burghes, A. H. and Beattie, C. E. (2003). Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding. J. Cell Biol. 162, 919-932.
79. Miller, R. G., Mitchell, J. D. and Moore, D. H. (2012). Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst. Rev. 3, CD001447.
80. Murray, L. M., Talbot, K. and Gillingwater, T. H. (2010). Review: neuromuscular synaptic vulnerability in motor neurone disease: amyotrophic lateral sclerosis and spinal muscular atrophy. Neuropathol. Appl. Neurobiol. 36, 133-156.
81. Namekawa, M., Ribai, P., Nelson, I., Forlani, S., Fellmann, F., Goizet, C., Depienne, C., Stevanin, G., Ruberg, M., Dürr, A. et al. (2006). SPG3A is the most frequent cause of hereditary spastic paraplegia with onset before age 10 years. Neurology 66, 112-114. (Pubitemid 43739604)
82. Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M. et al. (2006). Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130-133. (Pubitemid 44547757)
83. North, T. E., Goessling, W., Walkley, C. R., Lengerke, C., Kopani, K. R., Lord, A. M., Weber, G. J., Bowman, T. V., Jang, I. H., Grosser, T. et al. (2007). Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature 447, 1007-1011. (Pubitemid 46975751)
84. Novarino, G., Fenstermaker, A. G., Zaki, M. S., Hofree, M., Silhavy, J. L., Heiberg, A. D., Abdellateef, M., Rosti, B., Scott, E., Mansour, L. et al. (2014). Exome sequencing links corticospinal motor neuron disease to common neurodegenerative disorders. Science 343, 506-511.
85. Oprea, G. E., Kröber, S., McWhorter, M. L., Rossoll, W., Müller, S., Krawczak, M., Bassell, G. J., Beattie, C. E. and Wirth, B. (2008). Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy. Science 320, 524-527. (Pubitemid 351590664)
86. Ou, H. C., Cunningham, L. L., Francis, S. P., Brandon, C. S., Simon, J. A., Raible, D. W. and Rubel, E. W. (2009). Identification of FDA-approved drugs and bioactives that protect hair cells in the zebrafish (Danio rerio) lateral line and mouse (Mus musculus) utricle. J. Assoc. Res. Otolaryngol. 10, 191-203.
87. Owens, K. N., Santos, F., Roberts, B., Linbo, T., Coffin, A. B., Knisely, A. J., Simon, J. A., Rubel, E. W. and Raible, D. W. (2008). Identification of genetic and chemical modulators of zebrafish mechanosensory hair cell death. PLoS Genet. 4, e1000020.
88. Phillips, J. B. and Westerfield, M. (2014). Zebrafish models in translational research: tipping the scales toward advancements in human health. Dis. Model. Mech. 7, 739-743.
89. Postlethwait, J. H., Woods, I. G., Ngo-Hazelett, P., Yan, Y.-L., Kelly, P. D., Chu, F., Huang, H., Hill-Force, A. and Talbot, W. S. (2000). Zebrafish comparative genomics and the origins of vertebrate chromosomes. Genome Res. 10, 1890-1902. (Pubitemid 32049135)
90. Ramesh, T., Lyon, A. N., Pineda, R. H., Wang, C., Janssen, P. M. L., Canan, B. D., Burghes, A. H. M. and Beattie, C. E. (2010). A genetic model of amyotrophic lateral sclerosis in zebrafish displays phenotypic hallmarks of motoneuron disease. Dis. Model. Mech. 3, 652-662.
91. Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L. et al.; ITALSGEN Consortium (2011). A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72, 257-268.
92. Robberecht, W. and Philips, T. (2013). The changing scene of amyotrophic lateral sclerosis. Nat. Rev. Neurosci. 14, 248-264.
93. Roberts, J. A., Miguel-Escalada, I., Slovik, K. J., Walsh, K. T., Hadzhiev, Y., Sanges, R., Stupka, E., Marsh, E. K., Balciuniene, J., Balciunas, D. et al. (2014). Targeted transgene integration overcomes variability of position effects in zebrafish. Development 141, 715-724.
94. Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X. et al. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59-62. (Pubitemid 23087289)
95. Sakowski, S. A., Lunn, J. S., Busta, A. S., Oh, S. S., Zamora-Berridi, G., Palmer, M., Rosenberg, A. A., Philip, S. G., Dowling, J. J. and Feldman, E. L. (2012). Neuromuscular effects of G93A-SOD1 expression in zebrafish. Mol. Neurodegener. 7, 44.
96. Schmid, B. and Haass, C. (2013). Genomic editing opens new avenues for zebrafish as a model for neurodegeneration. J. Neurochem. 127, 461-470.
97. Schmid, B., Hruscha, A., Hogl, S., Banzhaf-Strathmann, J., Strecker, K., van der Zee, J., Teucke, M., Eimer, S., Hegermann, J., Kittelmann, M. et al. (2013). Loss of ALS-associated TDP-43 in zebrafish causes muscle degeneration, vascular dysfunction, and reduced motor neuron axon outgrowth. Proc. Natl. Acad. Sci. USA 110, 4986-4991.
98. See, K., Yadav, P., Giegerich, M., Cheong, P. S., Graf, M., Vyas, H., Lee, S. G., Mathavan, S., Fischer, U., Sendtner, M. et al. (2014). SMN deficiency alters Nrxn2 expression and splicing in zebrafish and mouse models of spinal muscular atrophy. Hum. Mol. Genet. 23, 1754-1770.
99. Sephton, C. F., Good, S. K., Atkin, S., Dewey, C. M., Mayer, P., III, Herz, J. and Yu, G. (2010). TDP-43 is a developmentally regulated protein essential for early embryonic development. J. Biol. Chem. 285, 6826-6834.
100. Sleeman, J. (2013). Small nuclear RNAs and mRNAs: linking RNA processing and transport to spinal muscular atrophy. Biochem. Soc. Trans. 41, 871-875.
101. Sleigh, J. N., Barreiro-Iglesias, A., Oliver, P. L., Biba, A., Becker, T., Davies, K. E., Becker, C. G. and Talbot, K. (2014). Chondrolectin affects cell survival and neuronal outgrowth in in vitro and in vivo models of spinal muscular atrophy. Hum. Mol. Genet. 23, 855-869.
102. Song, Y., Wang, M., Mao, F., Shao, M., Zhao, B., Song, Z., Shao, C. and Gong, Y. (2013). Knockdown of Pnpla6 protein results in motor neuron defects in zebrafish. Dis. Model. Mech. 6, 404-413.
103. Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J. C., Williams, K. L., Buratti, E. et al. (2008). TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319, 1668-1672. (Pubitemid 351432505)
104. Stevanin, G., Azzedine, H., Denora, P., Boukhris, A., Tazir, M., Lossos, A., Rosa, A. L., Lerer, I., Hamri, A., Alegria, P. et al.; SPATAX consortium (2008). Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration. Brain 131, 772-784. (Pubitemid 351294708)
105. Stoletov, K. and Klemke, R. (2008). Catch of the day: zebrafish as a human cancer model. Oncogene 27, 4509-4520.
106. Suster, M. L., Kikuta, H., Urasaki, A., Asakawa, K. and Kawakami, K. (2009). Transgenesis in zebrafish with the tol2 transposon system. Methods Mol. Biol. 561, 41-63.
107. Swarup, V., Phaneuf, D., Bareil, C., Robertson, J., Rouleau, G. A., Kriz, J. and Julien, J. P. (2011). Pathological hallmarks of amyotrophic lateral sclerosis/ frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments. Brain 134, 2610-2626.
108. Tat, J., Liu, M. and Wen, X. Y. (2013). Zebrafish cancer and metastasis models for in vivo drug discovery. Drug Discov. Today. Technol. 10, e83-e89.
109. Vaccaro, A., Patten, S. A., Ciura, S., Maios, C., Therrien, M., Drapeau, P., Kabashi, E. and Parker, J. A. (2012a). Methylene blue protects against TDP-43 and FUS neuronal toxicity in C. elegans and D. rerio. PLoS ONE 7, e42117.
110. Vaccaro, A., Tauffenberger, A., Aggad, D., Rouleau, G., Drapeau, P. and Parker, J. A. (2012b). Mutant TDP-43 and FUS cause age-dependent paralysis and neurodegeneration in C. elegans. PLoS ONE 7, e31321.
111. Vaccaro, A., Patten, S. A., Aggad, D., Julien, C., Maios, C., Kabashi, E., Drapeau, P. and Parker, J. A. (2013). Pharmacological reduction of ER stress protects against TDP-43 neuronal toxicity in vivo. Neurobiol. Dis. 55, 64-75.
112. Valdmanis, P. N., Meijer, I. A., Reynolds, A., Lei, A., MacLeod, P., Schlesinger, D., Zatz, M., Reid, E., Dion, P. A., Drapeau, P. et al. (2007). Mutations in the KIAA0196 gene at the SPG8 locus cause hereditary spastic paraplegia. Am. J. Hum. Genet. 80, 152-161. (Pubitemid 46047658)
113. Van Hoecke, A., Schoonaert, L., Lemmens, R., Timmers, M., Staats, K. A., Laird, A. S., Peeters, E., Philips, T., Goris, A., Dubois, B. et al. (2012). EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans. Nat. Med. 18, 1418-1422.
114. Vance, C., Rogelj, B., Hortobágyi, T., De Vos, K. J., Nishimura, A. L., Sreedharan, J., Hu, X., Smith, B., Ruddy, D., Wright, P. et al. (2009). Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323, 1208-1211.
115. Varshney, G. K. and Burgess, S. M. (2014). Mutagenesis and phenotyping resources in zebrafish for studying development and human disease. Brief. Funct. Genomics 13, 82-94.
116. Voigt, A., Herholz, D., Fiesel, F. C., Kaur, K., Müller, D., Karsten, P., Weber, S. S., Kahle, P. J., Marquardt, T. and Schulz, J. B. (2010). TDP-43-mediated neuron loss in vivo requires RNA-binding activity. PLoS ONE 5, e12247.
117. Wang, J.-W., Brent, J. R., Tomlinson, A., Shneider, N. A. and McCabe, B. D. (2011). The ALS-associated proteins FUS and TDP-43 function together to affect Drosophila locomotion and life span. J. Clin. Invest. 121, 4118-4126.
118. Wegorzewska, I. and Baloh, R. H. (2011). TDP-43-based animal models of neurodegeneration: new insights into ALS pathology and pathophysiology. Neurodegener. Dis. 8, 262-274.
119. White, R. M., Cech, J., Ratanasirintrawoot, S., Lin, C. Y., Rahl, P. B., Burke, C. J., Langdon, E., Tomlinson, M. L., Mosher, J., Kaufman, C. et al. (2011). DHODH modulates transcriptional elongation in the neural crest and melanoma. Nature 471, 518-522.
120. Wishart, T. M., Mutsaers, C. A., Riessland, M., Reimer, M. M., Hunter, G., Hannam, M. L., Eaton, S. L., Fuller, H. R., Roche, S. L., Somers, E. et al. (2014). Dysregulation of ubiquitin homeostasis and β-catenin signaling promote spinal muscular atrophy. J. Clin. Invest. 124, 1821-1834.
121. Wood, J. D., Landers, J. A., Bingley, M., McDermott, C. J., Thomas-McArthur, V., Gleadall, L. J., Shaw, P. J. and Cunliffe, V. T. (2006). The microtubulesevering protein Spastin is essential for axon outgrowth in the zebrafish embryo. Hum. Mol. Genet. 15, 2763-2771. (Pubitemid 44400403)
122. Workman, E., Saieva, L., Carrel, T. L., Crawford, T. O., Liu, D., Lutz, C., Beattie, C. E., Pellizzoni, L. and Burghes, A. H. (2009). A SMN missense mutation complements SMN2 restoring snRNPs and rescuing SMA mice. Hum. Mol. Genet. 18, 2215-2229.
123. Wu, L.-S., Cheng, W.-C., Hou, S.-C., Yan, Y.-T., Jiang, S.-T. and Shen, C. K. J. (2010). TDP-43, a neuro-pathosignature factor, is essential for early mouse embryogenesis. Genesis 48, 56-62.
124. Yamanaka, K., Miller, T. M., McAlonis-Downes, M., Chun, S. J. and Cleveland, D. W. (2006). Progressive spinal axonal degeneration and slowness in ALS2-deficient mice. Ann. Neurol. 60, 95-104.
125. Yoon, G., Baskin, B., Tarnopolsky, M., Boycott, K. M., Geraghty, M. T., Sell, E., Goobie, S., Meschino, W., Banwell, B. and Ray, P. N. (2013). Autosomal recessive hereditary spastic paraplegia-clinical and genetic characteristics of a welldefined cohort. Neurogenetics 14, 181-188.
126. Zhou, H., Huang, C., Chen, H., Wang, D., Landel, C. P., Xia, P. Y., Bowser, R., Liu, Y. J. and Xia, X. G. (2010). Transgenic rat model of neurodegeneration caused by mutation in the TDP gene. PLoS Genet. 6, e1000887.
127. Zivony-Elboum, Y., Westbroek, W., Kfir, N., Savitzki, D., Shoval, Y., Bloom, A., Rod, R., Khayat, M., Gross, B., Samri, W. et al. (2012). A founder mutation in Vps37A causes autosomal recessive complex hereditary spastic paraparesis. J. Med. Genet. 49, 462-472.
128. Zon, L. I. and Peterson, R. T. (2005). In vivo drug discovery in the zebrafish. Nat. Rev. Drug Discov. 4, 35-44 (Pubitemid 40109588)